High-resolution mapping of the 11q13 amplicon and identification of a gene, TAOS1, that is amplified and overexpressed in oral cancer cells

Amplification of chromosomal band 11q13 is a common event in human cancer. It has been reported in about 45% of head and neck carcinomas and in other cancers including esophageal, breast, liver, lung, and bladder cancer. To understand the mechanism of 11q13 amplification and to identify the potential oncogene(s) driving it, we have fine-mapped the structure of the amplicon in oral squamous cell carcinoma cell lines and localized the proximal and distal breakpoints. A 5-Mb physical map of the region has been prepared from which sequence is available. We quantified copy number of sequence-tagged site markers at 42–550 kb intervals along the length of the amplicon and defined the amplicon core and breakpoints by using TaqMan-based quantitative microsatellite analysis. The core of the amplicon maps to a 1.5-Mb region. The proximal breakpoint localizes to two intervals between sequence-tagged site markers, 550 kb and 160 kb in size, and the distal breakpoint maps to a 250 kb interval. The cyclin D1 gene maps to the amplicon core, as do two new expressed sequence tag clusters. We have analyzed one of these expressed sequence tag clusters and now report that it contains a previously uncharacterized gene, TAOS1 (tumor amplified and overexpressed sequence 1), which is both amplified and overexpressed in oral cancer cells. The data suggest that TAOS1 may be an amplification-dependent candidate oncogene with a role in the development and/or progression of human tumors, including oral squamous cell carcinomas. The approach described here should be useful for characterizing amplified genomic regions in a wide variety of tumors.

[1]  A. Tanigami,et al.  A 14-Mb physical map of the region at chromosome 11q13 harboring the MEN1 locus and the tumor amplicon region. , 1992, Genomics.

[2]  M. Schwab,et al.  Amplification of oncogenes revisited: from expression profiling to clinical application. , 2001, Cancer letters.

[3]  M. Gaffey,et al.  Chromosome 11q13 amplification in head and neck squamous cell carcinoma. Association with poor prognosis. , 1995, Archives of otolaryngology--head & neck surgery.

[4]  B. Trask,et al.  Sister chromatid fusion initiates amplification of the dihydrofolate reductase gene in Chinese hamster cells. , 1993, Genes & development.

[5]  W. Hittelman,et al.  Chromosome breakage at a major fragile site associated with P-glycoprotein gene amplification in multidrug-resistant CHO cells , 1994, Molecular and cellular biology.

[6]  J. Bartek,et al.  Amplification of chromosome band 11q13 and a role for cyclin D1 in human breast cancer. , 1995, Cancer letters.

[7]  F. Mitelman,et al.  Chromosomal abnormalities involving 11q13 are associated with poor prognosis in patients with squamous cell carcinoma of the head and neck , 1995, Cancer.

[8]  J. Cairns,et al.  Amplification at chromosome 11q13 in transitional cell tumours of the bladder. , 1991, Oncogene.

[9]  E. Schuuring,et al.  Visualization of mono-allelic chromosomal aberrations 3′ and 5′ of the cyclin D1 gene in mantle cell lymphoma using DNA fiber fluorescence in situ hybridization , 1997, Oncogene.

[10]  S. Hanash,et al.  A minimal critical region of the 8p22-23 amplicon in esophageal adenocarcinomas defined using sequence tagged site-amplification mapping and quantitative polymerase chain reaction includes the GATA-4 gene. , 2000, Cancer research.

[11]  David I. Smith,et al.  A role for common fragile site induction in amplification of human oncogenes. , 2002, Cancer cell.

[12]  D. Birnbaum,et al.  Patterns of dna amplification at band q13 of chromosome 11 in human breast cancer , 1994, Genes, chromosomes & cancer.

[13]  C. Auffray,et al.  The I.M.A.G.E. Consortium: an integrated molecular analysis of genomes and their expression. , 1996, Genomics.

[14]  F. Hall,et al.  Inhibition of Cell Proliferation in Head and Neck Squamous Cell Carcinoma Cell Lines with Antisense Cyclin D1 , 1998, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.

[15]  S. Gollin,et al.  Visualization of INT2 and HST1 Amplification in oral squamous cell carcinomas , 1995, Genes, chromosomes & cancer.

[16]  D. Horsfall,et al.  EMS1 amplification can occur independently of CCND1 or INT-2 amplification at 11q13 and may identify different phenotypes in primary breast cancer , 1997, Oncogene.

[17]  B. Klein,et al.  Rearrangement of CCND1 (BCL1/PRAD1) 3' untranslated region in mantle-cell lymphomas and t(11q13)-associated leukemias. , 1994, Blood.

[18]  M. Schwab.  Amplification of oncogenes in human cancer cells , 1998, BioEssays : news and reviews in molecular, cellular and developmental biology.

[19]  W. Kuo,et al.  Quantitative mapping of amplicon structure by array CGH identifies CYP24 as a candidate oncogene , 2000, Nature Genetics.

[20]  G Buttin,et al.  Co‐amplified markers alternate in megabase long chromosomal inverted repeats and cluster independently in interphase nuclei at early steps of mammalian gene amplification. , 1992, The EMBO journal.

[21]  J. Todd,et al.  Framework YAC contig anchored into a 3.2-Mb high-resolution physical map in proximal 11q13. , 1997, Genomics.

[22]  C. Theillet,et al.  Amplification of 11q13 DNA sequences in human breast cancer: D11S97 identifies a region tightly linked to BCL1 which can be amplified separately. , 1992, Oncogene.

[23]  C. Bartram,et al.  Spectrum of transforming sequences detected by tumorigenicity assay in a large series of human neoplasms , 1999, International journal of cancer.

[24]  T. Godfrey,et al.  Measurement of DNA copy number at microsatellite loci using quantitative PCR analysis. , 2000, Cancer research.

[25]  F. Couch,et al.  Structural analysis of the 17q22-23 amplicon identifies several independent targets of amplification in breast cancer cell lines and tumors. , 2001, Cancer research.

[26]  R. Kuick,et al.  Identification and characterization of a 19q12 amplicon in esophageal adenocarcinomas reveals cyclin E as the best candidate gene for this amplicon. , 2000, Cancer research.

[27]  U. Bockmühl,et al.  Verbesserte Prognoseeinschätzung bei Kopf-Hals-Karzinomen durch neue genetische Marker , 2000, HNO.

[28]  D. Birnbaum,et al.  Detailed map of a region commonly amplified at 11q13-->q14 in human breast carcinoma. , 1997, Cytogenetics and cell genetics.

[29]  A. Jauch,et al.  Concurrent activation of a novel putative transforming gene, myeov, and cyclin D1 in a subset of multiple myeloma cell lines with t(11;14)(q13;q32). , 2000, Blood.

[30]  D. Le Paslier,et al.  A 5.5-Mb high-resolution integrated map of distal 11q13. , 1997, Genomics.

[31]  P. Szepetowski,et al.  Mapping genes according to their amplification status in tumor cells: contribution to the map of 11q13. , 1993, Genomics.

[32]  A. Hart,et al.  Overexpression of cyclin D1 correlates with recurrence in a group of forty-seven operable squamous cell carcinomas of the head and neck. , 1995, Cancer research.

[33]  M. L. Le Beau,et al.  A consistent pattern of RIN1 rearrangements in oral squamous cell carcinoma cell lines supports a breakage‐fusion‐bridge cycle model for 11q13 amplification , 2000, Genes, chromosomes & cancer.

[34]  M. Höglund,et al.  FISH characterization of head and neck carcinomas reveals that amplification of band 11q13 is associated with deletion of distal 11q , 1998, Genes, chromosomes & cancer.

[35]  D. Birnbaum,et al.  DNA amplification at 11q13 in human cancer: from complexity to perplexity. , 1992, Mutation research.

[36]  F. Toledo,et al.  Expression of Fragile Sites Triggers Intrachromosomal Mammalian Gene Amplification and Sets Boundaries to Early Amplicons , 1997, Cell.

[37]  N. Park,et al.  Immortalization of normal human oral keratinocytes with type 16 human papillomavirus. , 1991, Carcinogenesis.

[38]  T. Godfrey,et al.  Quantitative mRNA expression analysis from formalin-fixed, paraffin-embedded tissues using 5' nuclease quantitative reverse transcription-polymerase chain reaction. , 2000, The Journal of molecular diagnostics : JMD.

[39]  E. Schuuring.  The involvement of the chromosome 11q13 region in human malignancies: cyclin D1 and EMS1 are two new candidate oncogenes--a review. , 1995, Gene.

[40]  S. Gollin.  Chromosomal alterations in squamous cell carcinomas of the head and neck: Window to the biology of disease , 2001, Head & neck.